Revision as of 13:12, 14 July 2006 editYurikBot (talk | contribs)278,165 editsm robot Adding: de:Stiff-man-Syndrom← Previous edit | Revision as of 14:21, 23 July 2006 edit undoArcadian (talk | contribs)163,050 edits outline and linksNext edit → | ||
Line 1: | Line 1: | ||
{{Infobox_Disease | | |||
⚫ | '''Stiff person syndrome''' (SPS) (or occasionally, '''stiff-man syndrome''') is a rare ] disorder of unknown ]. |
||
Name = {{PAGENAME}} | | |||
Image = | | |||
Caption = | | |||
DiseasesDB = 12428 | | |||
ICD10 = {{ICD10|G|25|8|g|20}} | | |||
ICD9 = {{ICD9|333.91}} | | |||
ICDO = | | |||
OMIM = | | |||
MedlinePlus = | | |||
eMedicineSubj = neuro | | |||
eMedicineTopic = 353 | | |||
MeshName = Stiff-Person+Syndrome | | |||
MeshNumber = C10.114.812 | | |||
}} | |||
⚫ | '''Stiff person syndrome''' (SPS) (or occasionally, '''stiff-man syndrome''') is a rare ] disorder of unknown ]. | ||
==History== | |||
SPS was first described by Moersch and Woltman at the ] in 1956 {{ref|mws}}. | |||
==Symptoms and prognosis== | |||
Those with the illness experience progressive, fluctuating tonic contractions of all ]s, particularly the ] musculature. An inability to ] and general ] quickly follow; death usually occurs six to twelve months after diagnosis. | Those with the illness experience progressive, fluctuating tonic contractions of all ]s, particularly the ] musculature. An inability to ] and general ] quickly follow; death usually occurs six to twelve months after diagnosis. | ||
==Treatment== | |||
Treatment is mostly ] with muscle relaxants such as ], which lose their effectiveness as the illness progresses. Because many patients with SPS have circulating antibodies to ], an ] cause the disease has been postulated. In the absence of ], ]-controlled ] to determine treatment efficacy, some authorities recommend humane trials of ] therapy, ] or ] ] infusion. | Treatment is mostly ] with muscle relaxants such as ], which lose their effectiveness as the illness progresses. Because many patients with SPS have circulating antibodies to ], an ] cause the disease has been postulated. In the absence of ], ]-controlled ] to determine treatment efficacy, some authorities recommend humane trials of ] therapy, ] or ] ] infusion. | ||
Line 8: | Line 28: | ||
* {{note|mws}} {{cite journal | author=MOERSCH FP, WOLTMAN HW | title=Progressive fluctuating muscular rigidity and spasm ("stiff-man" syndrome); report of a case and some observations in 13 other cases | journal=Mayo Clin Proc | year=1956 | pages=421-7 | volume=31 | issue=15 | id=PMID 13350379}} | * {{note|mws}} {{cite journal | author=MOERSCH FP, WOLTMAN HW | title=Progressive fluctuating muscular rigidity and spasm ("stiff-man" syndrome); report of a case and some observations in 13 other cases | journal=Mayo Clin Proc | year=1956 | pages=421-7 | volume=31 | issue=15 | id=PMID 13350379}} | ||
* {{cite journal | author=Murinson BB | title=Stiff-person syndrome | journal=Neurologist | year=2004 | pages=131-7 | volume=10 | issue=3 | id=PMID 15140273}} | * {{cite journal | author=Murinson BB | title=Stiff-person syndrome | journal=Neurologist | year=2004 | pages=131-7 | volume=10 | issue=3 | id=PMID 15140273}} | ||
==See also== | |||
* ] | |||
==External Links== | ==External Links== | ||
* - A site about the link between GAD and SPS | * - A site about the link between GAD and SPS | ||
* {{NINDS|stiffperson}} | |||
* | |||
* | |||
] | ] |
Revision as of 14:21, 23 July 2006
Medical conditionStiff-person syndrome | |
---|---|
Specialty | Neurology |
Frequency | 8e-05% |
Stiff person syndrome (SPS) (or occasionally, stiff-man syndrome) is a rare neurologic disorder of unknown etiology.
History
SPS was first described by Moersch and Woltman at the Mayo Clinic in 1956 .
Symptoms and prognosis
Those with the illness experience progressive, fluctuating tonic contractions of all muscles, particularly the axial musculature. An inability to walk and general paralysis quickly follow; death usually occurs six to twelve months after diagnosis.
Treatment
Treatment is mostly palliative with muscle relaxants such as benzodiazepines, which lose their effectiveness as the illness progresses. Because many patients with SPS have circulating antibodies to glutamic acid decarboxylase, an autoimmune cause the disease has been postulated. In the absence of double-blind, placebo-controlled class A trials to determine treatment efficacy, some authorities recommend humane trials of immunosuppressive therapy, plasmapheresis or intravenous immunoglobulin infusion.
References
- MOERSCH FP, WOLTMAN HW (1956). "Progressive fluctuating muscular rigidity and spasm ("stiff-man" syndrome); report of a case and some observations in 13 other cases". Mayo Clin Proc. 31 (15): 421–7. PMID 13350379.
- Murinson BB (2004). "Stiff-person syndrome". Neurologist. 10 (3): 131–7. PMID 15140273.
See also
External Links
- Neuroimmunology, The Medical School, Birmingham University - A site about the link between GAD and SPS
- stiffperson at NINDS
- Article at clevelandclinic.org
- Article at eNotes